| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.29 | 0.3 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |